谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Biomarkers of Response to First-Line Nivolumab Therapy in Patients with Advanced Renal Cell Carcinoma (RCC) Enrolled in the HCRN GU16-260 Trial.

Nourhan El Ahmar,Sayed Matar,Opeyemi Jegede, Varunika Savla,Aseman Bagheri Sheshdeh,Fatme Ghandour,Thomas Denize,Destiny West,Toni K. Choueiri,Paul J. Catalano,David A. Braun,Naomi B. Haas,Hans J. Hammers,Mehmet Asim Bilen,Mark N. Stein,Jeffrey A. Sosman,Catherine J. Wu,David F. McDermott,Michael B. Atkins,Sabina Signoretti

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要